7
Participants
Start Date
November 4, 2022
Primary Completion Date
November 23, 2022
Study Completion Date
December 16, 2022
PEAR-002B
PEAR-002B is a novel prescription digital therapeutic to support unobserved buprenorphine initiation and adherence in Opioid Use Disorder
reSET-O
reSET-O is an FDA-authorized mobile application treatment for opioid use disorder.
Hassman Research Institute, LLC, Berlin
Lead Sponsor
Kaiser Foundation Research Institute
OTHER
Whitman-Walker Institute, Inc.
OTHER_GOV
National Institute on Drug Abuse (NIDA)
NIH
Hassman Research Institute, LLC
UNKNOWN
Pear Therapeutics, Inc.
INDUSTRY